Home/Thiogenesis Therapeutics/Patrice P. Rioux, MD, PhD
PP

Patrice P. Rioux, MD, PhD

CEO

Thiogenesis Therapeutics

Thiogenesis Therapeutics Pipeline

DrugIndicationPhase
TTI-0102Nephropathic CystinosisPhase 3 (planned)